Two different experimental mRNA vaccines have ‘now shown remarkable effectiveness of about 95 percent in preventing COVID-19 infection in adults,’ stated the U.S. Food and Drug Administration (FDA) leadership on January 4, 2020.
Read More
![](https://covid19.healthcare.pro/wp-content/uploads/2021/01/daniel-schludi-mAGZNECMcUg-unsplash-1_0.jpg)
Two different experimental mRNA vaccines have ‘now shown remarkable effectiveness of about 95 percent in preventing COVID-19 infection in adults,’ stated the U.S. Food and Drug Administration (FDA) leadership on January 4, 2020.
Read More